EUVIMEDEUVIMED entdecken
Crossref

Molecular epidemiology of bacteraemic vancomycin-resistant Enterococcus faecium isolates and in vitro activities of SC5005 and other comparators against these isolates collected from a medical centre in northern Taiwan, 2019–2020

Tsai-Wen Wan, Hui-Hui Yeo, Tai-Fen Lee, Yu-Tsung Huang, Po-Ren Hsueh, Hao-Chieh Chiu iD

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkac414 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Tsai-Wen Wan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan. Hauptthemen laut MEDLINE: Enterococcus faecium, Gram-Positive Bacterial Infections, Vancomycin-Resistant Enterococci. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, National Taiwan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The global prevalence of vancomycin-resistant Enterococcus faecium (VREfm) highlights the need for new anti-enterococcal agents. Here, we assessed the molecular epidemiology of clinical VREfm bacteraemic isolates from a medical centre in northern Taiwan in 2019–2020 and to evaluate their susceptibility to last-line antibiotics and a new antimicrobial agent, SC5005.

Methods

The molecular epidemiology of VREfm was investigated using van genotyping, MLST and PFGE. The susceptibilities of VREfm strains to antibiotics and SC5005 were determined using the agar dilution and broth microdilution methods. The capability of E. faecium to develop resistance to antibiotics and SC5005 was evaluated using frequency of resistance and multipassage resistance assays. The mode of action of SC5005 was assessed by time-kill, bacterial membrane integrity and membrane potential assays.

Results

All 262 VREfm isolates harboured vanA gene, and the most prevalent sequence type was ST17 (51%, n = 134, 84 pulsotypes), followed by ST78 (25%, n = 65, 54 pulsotypes). Additionally, we identified four new STs (ST2101, ST2102, ST2135 and ST2136) and observed the arrival of multidrug-resistant ST1885 in Taiwan. Moreover, SC5005 was effective against all VREfm isolates, including those non-susceptible to last-line antibiotics. SC5005 can disrupt and depolarize the bacterial membrane to kill E. faecium without detectable resistance.

Conclusions

The findings provide insights into the latest epidemiology and resistance profiles of bacteraemic-causing VREfm in northern Taiwan. Additionally, SC5005 has the potential for development as a new therapeutic to treat VREfm infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterococcus faeciumGram-Positive Bacterial InfectionsVancomycin-Resistant EnterococciHumansAnti-Bacterial AgentsBacterial ProteinsMolecular EpidemiologyMultilocus Sequence TypingTaiwanVancomycinVancomycin ResistancePhenylurea Compounds

Substanzen

Anti-Bacterial AgentsBacterial ProteinsVancomycinSC5005Phenylurea Compounds

Autor:innen und Institutionen

  • Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Departments of Laboratory Medicine and Internal Medicine, China Medical University Hospital, Taichung, Taiwan.

ORCID-Profile: Hao-Chieh Chiu

Förderung

  • Ministry of Science and Technology, Taiwan
  • National Taiwan University

Zitieren

APA

Wan, T. W., Yeo, H. H., Lee, T. F., Huang, Y. T., Hsueh, P. R., & Chiu, H. C. (2023). Molecular epidemiology of bacteraemic vancomycin-resistant Enterococcus faecium isolates and in vitro activities of SC5005 and other comparators against these isolates collected from a medical centre in northern Taiwan, 2019–2020. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkac414

Vancouver

Wan TW, Yeo HH, Lee TF, Huang YT, Hsueh PR, Chiu HC. Molecular epidemiology of bacteraemic vancomycin-resistant Enterococcus faecium isolates and in vitro activities of SC5005 and other comparators against these isolates collected from a medical centre in northern Taiwan, 2019–2020. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkac414

BibTeX
@article{Wan2023,
  author = {Wan, Tsai-Wen and Yeo, Hui-Hui and Lee, Tai-Fen and Huang, Yu-Tsung and Hsueh, Po-Ren and Chiu, Hao-Chieh},
  title = {Molecular epidemiology of bacteraemic vancomycin-resistant Enterococcus faecium isolates and in vitro activities of SC5005 and other comparators against these isolates collected from a medical centre in northern Taiwan, 2019–2020},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkac414}
}
Kostenlos starten →